heart attack

Views & Analysis

Recent research suggests that the ways in which men and women describe heart attack symptoms differently can affect diagnosis in urgent situations.

News

Novartis to discuss canakinumab results with regulators.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.